戻る Agenda
Digital Disruptors: What Do We Mean?
Session Chair(s)
Jonathan Palmer
Enterprise Solutions
Medidata, United Kingdom
There is a huge opportunity for significant change in Clinical research, by embracing Digital Approaches such as mHealth, wearables, Patient Apps, remote monitoring, siteless trials, digital therapies, EHR integration. What will this disruption mean and how can we harness the potential of digital for better healthcare?
Speaker(s)
Panel Discussion
Isabelle de Zegher, DrMed, MD, MS, MSC
b!loba, Belgium
Founder
Panel Discussion
Chris Walker, MSC
Amgen, United Kingdom
VP, Head of Regulatory Affairs (EU,LATAM,MiddleEast,Africa,CAN)
Panel Discussion
Jeremy Wyatt, MBA
ActiGraph, United States
CEO